当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Exact Prediction of Various Anticancer Medication Efficacy Using Multi Target Regression and Support Vector Regression Analysis

Germano Almeida

Cancer remains a significant global health concern, and the development of effective anticancer medications is crucial for improving patient outcomes. However, predicting the efficacy of different anticancer drugs is a complex task due to the heterogeneity of cancer and the multifactorial nature of drug response. In this study, we propose a novel approach that combines multi-target regression and support vector regression analysis to accurately predict the efficacy of various anticancer medications. The selection of appropriate anticancer medications for individual patients is a challenging task. While several predictive models have been developed, most of them focus on single drugs and fail to capture the intricate relationships between multiple drugs and their targets. To overcome these limitations, we present a comprehensive framework that utilizes multi-target regression and support vector regression analysis for precise prediction of anticancer medication efficacy. To further enhance the predictive performance, we integrate support vector regression analysis into our framework. Support vector regression is a powerful machine learning algorithm that can effectively handle high-dimensional datasets and nonlinear relationships. It allows us to build robust models that can accurately predict anticancer medication efficacy.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。